Medicines are inaccessible for the majority of West Africans. This inaccessibility contributes to the persistence and spread of diseases in the ECOWAS region. Although production capacity exists in the region, most of the medicines are still imported. Furthermore, production and efficacy of medicines and vaccines depend on several factors among which are, an effective regulatory regime, enforcement of legislation, quality control, pharmacovigilance and safety, adequate application of intellectual property flexibilities, procurement and storage systems, prescription, delivery and rational use of medicines, development of capacities in specialised human resources as well as innovation, research and development.
The inadequate accessibility of medicines, vaccines and other health products, limits universal health coverage in the region.
Improve access to essential medicines, vaccines and other health products.
Access to essential medicines, vaccines and other health products improved
- Other health products
- Srengthen the capacities of pharmaceutical units in the region including the National Medicines Regulatory Authorities;
- Facilitate the integration of intellectual property flexibilities into national policies and legislation;
- Faciliate the development and implementation of policies for promoting innovation, research and development of pharmaceutical products;
- Improve access to quality medicines
- Supporting local pharmaceutical production
- Strengthening the procurement and distribution chain
- Building capacities for regulation and the regional harmonization process
- Improving quality assurance systems
- Strengthening strategies for controlling counterfeiting and the illicit trade in medicines and vaccines
- Implementation of intellectual property rights on pharmaceutical products;
- Strengthening innovation, research and development of medicines, vaccines and other health products.
- Regional strategy of procurement in medicines and vaccines developed
- Regional security stock of medicines, vaccines and other health products strengthened;
- Pharmaceutical raw materials exempted from all taxes;
- Capacities of quality control laboratories improved;
- Capacities of National Pharmaceutical Regulatory Authorities strengthened;
- Centre for research in bioequivalence and biopharmacy established;
- WAHO’s system for certification and pre-qualification established
- A web site for better sharing of information on pharamceutical data developed.
- A harmonized regional strategy for pharmacovigilance developed.
- A situational analysis of counterfeiting and illicit trade in medicines, vaccines and other health products in the region conducted.